Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 3 Interventional

Treatment of Rheumatoid Arthritis With Marine and Botanical Oils

ClinicalTrials.gov ID: NCT00072982

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00072982. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 6:59 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The object of this study is to determine whether treatment of rheumatoid arthritis (RA) with a combination of fish oil and borage seed oil is superior to treatment with either oil alone. This study will also investigate the biochemical, immunological, and molecular mechanism responsible for the therapeutic effects of these fatty acids. Each patient will be followed for eighteen months.

Study identification

NCT ID
NCT00072982
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 3
Enrollment
156 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2006 (Type not available)
Primary completion
May 2008 (Actual)
Completion
Nov 2008 (Estimated)
Last update posted
Aug 25, 2008

2006 – 2008

United States locations

U.S. sites
13
U.S. states
8
U.S. cities
12
Facility City State ZIP Site status
UAB Arthritis Clinical Intervention Program Birmingham Alabama 35297 —
New England Res. Associates Trumbull Connecticut 06611 —
RASF Clinical Research Center Boca Raton Florida 33486 —
Lake Rheumatology Tavares Florida 32778 —
Fallon Clinic Health Care Worcester Massachusetts 01605 —
Division of Rheumatology, Umass Memorial Health Care Worcester Massachusetts 01655 —
Rheumatology and Internal Medicine Associates of West County, PC St Louis Missouri 63131 —
Joel M. Kremer Albany New York 12206 —
Prem Tambar, MD Niagara Falls New York 14303 —
Bryn Mawr Medical Specialists Bryn Mawr Pennsylvania 19010 —
Geisinger Medical Center Danville Pennsylvania 17822 —
Altoona Center for Clinical Research Duncansville Pennsylvania 16635 —
Piedmont Arthritis Clinic Greenville South Carolina 29601 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00072982, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 25, 2008 · Synced Nov 13, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.